JP2001500850A5 - - Google Patents

Download PDF

Info

Publication number
JP2001500850A5
JP2001500850A5 JP1998510779A JP51077998A JP2001500850A5 JP 2001500850 A5 JP2001500850 A5 JP 2001500850A5 JP 1998510779 A JP1998510779 A JP 1998510779A JP 51077998 A JP51077998 A JP 51077998A JP 2001500850 A5 JP2001500850 A5 JP 2001500850A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP1998510779A
Other languages
English (en)
Other versions
JP2001500850A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/013871 external-priority patent/WO1998007718A1/en
Publication of JP2001500850A publication Critical patent/JP2001500850A/ja
Publication of JP2001500850A5 publication Critical patent/JP2001500850A5/ja
Abandoned legal-status Critical Current

Links

Description

Figure 2001500850
Figure 2001500850
Figure 2001500850
Figure 2001500850
Figure 2001500850
Figure 2001500850
Figure 2001500850
Figure 2001500850
JP10510779A 1996-08-22 1997-08-06 非―ペプチドボンベシン受容体アンタゴニスト Abandoned JP2001500850A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2432396P 1996-08-22 1996-08-22
US60/024,323 1996-08-22
PCT/US1997/013871 WO1998007718A1 (en) 1996-08-22 1997-08-06 Non-peptide bombesin receptor antagonists

Publications (2)

Publication Number Publication Date
JP2001500850A JP2001500850A (ja) 2001-01-23
JP2001500850A5 true JP2001500850A5 (ja) 2005-04-07

Family

ID=21819999

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10510779A Abandoned JP2001500850A (ja) 1996-08-22 1997-08-06 非―ペプチドボンベシン受容体アンタゴニスト

Country Status (17)

Country Link
US (1) US6194437B1 (ja)
EP (1) EP0920424B1 (ja)
JP (1) JP2001500850A (ja)
AT (1) ATE311383T1 (ja)
AU (1) AU733226B2 (ja)
BR (1) BR9711342A (ja)
CA (1) CA2255966A1 (ja)
DE (1) DE69734773T2 (ja)
ES (1) ES2253782T3 (ja)
IL (1) IL127194A0 (ja)
IS (1) IS4937A (ja)
NO (1) NO312669B1 (ja)
NZ (1) NZ333038A (ja)
PL (1) PL331710A1 (ja)
TR (1) TR199900364T2 (ja)
WO (1) WO1998007718A1 (ja)
ZA (1) ZA977526B (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030069231A1 (en) 1999-10-12 2003-04-10 Klaus Rudolf Modified aminoacids, pharmaceuticals containing these compounds and method for their production
IL135313A0 (en) * 1997-12-16 2001-05-20 Warner Lambert Co 1-substituted-1-aminomethylcycloalkane derivatives (gabapentin analogues), their preparation and their use in the treatment of neurological disorders
AU2180600A (en) 1998-12-18 2000-07-12 Warner-Lambert Company Non-peptide nk1 receptors antagonists
AU3033100A (en) 1999-01-18 2000-08-01 Boehringer Ingelheim International Gmbh Substituted imidazoles, their preparation and use
GB2369118A (en) * 2000-11-17 2002-05-22 Warner Lambert Co Bombesin receptor antagonists
EP1333829A1 (en) * 2000-11-17 2003-08-13 Warner-Lambert Company LLC Treatment of sexual dysfunction using bombesin antagonists
GB2369117A (en) * 2000-11-17 2002-05-22 Warner Lambert Co Bombesin receptor antagonists
HUP0301892A3 (en) * 2000-11-17 2005-06-28 Warner Lambert Company Llc Mor Pharmaceutical compositions for treatment of sexual dysfunction and their preparation
CN1461217A (zh) * 2000-12-20 2003-12-10 沃纳-兰伯特公司 非肽铃蟾肽受体拮抗物对治疗焦虑和恐慌紊乱症的新应用
ES2200617B1 (es) * 2001-01-19 2005-05-01 Almirall Prodesfarma, S.A. Derivados de urea como antagonistas de integrinas alfa 4.
DE10123163A1 (de) 2001-05-09 2003-01-16 Gruenenthal Gmbh Substituierte Cyclohexan-1,4-diaminderivate
US20030031627A1 (en) * 2001-07-31 2003-02-13 Mallinckrodt Inc. Internal image antibodies for optical imaging and therapy
US8612005B2 (en) * 2002-02-01 2013-12-17 The Cleveland Clinic Foundation Neurostimulation for affecting sleep disorders
WO2003092670A1 (en) * 2002-05-03 2003-11-13 Warner-Lambert Company Llc Bombesin antagonists
US7244743B2 (en) 2002-06-05 2007-07-17 Solvay Pharmaceuticals Gmbh Non-peptidic BRS-3 agonists
EP1539686A1 (en) * 2002-09-11 2005-06-15 Warner-Lambert Company Llc Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
US7595312B2 (en) * 2002-10-25 2009-09-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
US6846836B2 (en) * 2003-04-18 2005-01-25 Bristol-Myers Squibb Company N-substituted phenylurea inhibitors of mitochondrial F1F0 ATP hydrolase
GB0403578D0 (en) * 2004-02-18 2004-03-24 Biofocus Discovery Ltd Compounds which interact with the G-protein coupled receptor family
DE102004015723A1 (de) * 2004-03-29 2005-10-20 Boehringer Ingelheim Pharma Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
US7795385B2 (en) * 2004-12-17 2010-09-14 Bexar Global, Inc. Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
US8101580B2 (en) 2005-04-21 2012-01-24 Astellas Pharma Inc. Therapeutic agent for irritable bowel syndrome
EP1976513B1 (en) * 2006-01-06 2016-08-24 Sunovion Pharmaceuticals Inc. Cycloalkylamines as monoamine reuptake inhibitors
JPWO2015152128A1 (ja) * 2014-03-31 2017-04-13 長瀬産業株式会社 アミノ酸前駆体、アミノ酸およびその製造方法、ならびに該アミノ酸を用いたｐｅｔ診断用トレーサー
CN105884674B (zh) * 2015-01-05 2019-07-26 南开大学 色氨酸衍生物及制备方法和在防治植物病毒、杀菌、杀虫方面的应用
GB2561540A (en) * 2017-03-13 2018-10-24 Nodthera Ltd Chemical compounds

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000297A (en) 1971-05-18 1976-12-28 Rotta Research Laboratorium S.P.A. N-p-chlorobenzoyl tryptophane, salts and compositions thereof
US4639451A (en) 1981-10-20 1987-01-27 Mitsui Toatsu Kagaku-Kabushiki Kaisha Pyridazinone derivatives
FR2546517B1 (fr) 1983-05-24 1987-04-24 Panmedica Nouveaux dipeptides du -l-5-hydroxy-tryptophane, procedes pour leur preparation et medicaments les contenant
EP0288965A2 (de) 1987-04-29 1988-11-02 Hoechst Aktiengesellschaft Peptide mit Phospholipase A2- hemmender Wirkung
US5378803A (en) 1987-12-11 1995-01-03 Sterling Winthrop Inc. Azole-fused peptides and processes for preparation thereof
US5346907A (en) 1988-04-05 1994-09-13 Abbott Laboratories Amino acid analog CCK antagonists
US5153226A (en) * 1989-08-31 1992-10-06 Warner-Lambert Company Acat inhibitors for treating hypocholesterolemia
CA2088195A1 (en) 1990-08-31 1992-03-01 David C. Horwell Cholecystokinin antagonists, their preparation and therapeutic use
EP0593559A1 (en) * 1991-07-05 1994-04-27 MERCK SHARP & DOHME LTD. Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
WO1993001160A1 (en) 1991-07-05 1993-01-21 Merck Sharp & Dohme Limited Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
WO1993001159A1 (en) 1991-07-10 1993-01-21 Merck Sharp & Dohme Limited Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy
EP0593615B1 (en) 1991-07-10 1996-01-31 MERCK SHARP & DOHME LTD. Aromatic compounds, compositions containing them and their use in therapy
FR2687147A1 (fr) * 1992-02-11 1993-08-13 Union Pharma Scient Appl Nouveaux derives d'alpha-amino n-pyridyl benzene propanamide, leurs procedes de preparation, compositions pharmaceutiques les contenant.
RU94046149A (ru) 1992-05-28 1996-11-27 Пфайзер Инк. (US) Новые n-арил и n-гетероарил производные мочевины как ингибиторы ацил кофермента а:холестерин ацил трансферазы (асат) фармацевтическая композиция, способ ингибирования (асат)
EP1000930A3 (en) * 1992-08-13 2003-10-29 Warner-Lambert Company Tachykinin antagonists
US5340798A (en) 1992-10-14 1994-08-23 Merck & Co., Inc. Fibrinogen receptor antagonists
AU672699B2 (en) 1993-06-30 1996-10-10 Sankyo Company Limited Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
JPH07101929A (ja) 1993-10-01 1995-04-18 Fujisawa Pharmaceut Co Ltd 尿素誘導体およびその製造法
US5470834A (en) 1993-10-06 1995-11-28 Florida State University Sulfoximine and suldodiimine matrix metalloproteinase inhibitors
US5455262A (en) 1993-10-06 1995-10-03 Florida State University Mercaptosulfide metalloproteinase inhibitors

Similar Documents

Publication Publication Date Title
JP2000502280A5 (ja)
JP2000501771A5 (ja)
JP2000514474A5 (ja)
JP2001501104A5 (ja)
JP2000501599A5 (ja)
JP2000500076A5 (ja)
JP2001502005A5 (ja)
JP2000501324A5 (ja)
JP2000502472A5 (ja)
JP2000501338A5 (ja)
JP2000501825A5 (ja)
JP2000515510A5 (ja)
JP2000502485A5 (ja)
JP2000501774A5 (ja)
JP2000502425A5 (ja)
JP2000502570A5 (ja)
JP2000502568A5 (ja)
JP2001507180A5 (ja)
JP2000501876A5 (ja)
JP2001504107A5 (ja)
JP2000501744A5 (ja)
JP2000513976A5 (ja)
JP2000502316A5 (ja)
JP2000502714A5 (ja)
JP2000501229A5 (ja)